China Pharma M&A Among Three Hotspots For Healthcare Investment
This article was originally published in PharmAsia News
Executive Summary
The pharmaceutical industry has become a hot area in China that is attracting all kinds of capital. There were 89 cases of investment in, or mergers and acquisitions of, biopharmaceutical companies listed in the A-share market by Sept. 15 this year.